{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T08:40:40Z","timestamp":1792744840716,"version":"4.5.0"},"reference-count":29,"publisher":"e-Century Publishing Corporation","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Cancer Res"],"DOI":"10.62347\/vzmv3943","type":"journal-article","created":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T08:46:47Z","timestamp":1773132407000},"page":"639-649","source":"Crossref","is-referenced-by-count":0,"title":["PDE4C stabilized by ELAVL1 promotes lymph node metastasis in papillary thyroid cancer"],"prefix":"10.62347","volume":"16","author":[{"given":"Tingting","family":"Cui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"48694","published-online":{"date-parts":[[2026]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1001\/jama.2023.26348","article-title":"Thyroid cancer: a review","volume":"331","author":"Boucai","year":"2024","unstructured":"Boucai L, Zafereo M and Cabanillas ME. Thyroid cancer: a review. JAMA 2024; 331: 425-435.","journal-title":"JAMA"},{"key":"ref1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-1-0716-2505-7_1","article-title":"Papillary thyroid carcinoma: current position in epidemiology, genomics, and classification","volume":"2534","author":"Lam","year":"2022","unstructured":"Lam AK. Papillary thyroid carcinoma: current position in epidemiology, genomics, and classification. Methods Mol Biol 2022; 2534: 1-15.","journal-title":"Methods Mol Biol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"5456","DOI":"10.21037\/qims-22-1334","article-title":"Surgical resection following therapy with anlotinib in locally advanced papillary thyroid carcinoma: a case description","volume":"13","author":"Zhang","year":"2023","unstructured":"Zhang J, Chen C, Yang Y and Zhang B. Surgical resection following therapy with anlotinib in locally advanced papillary thyroid carcinoma: a case description. Quant Imaging Med Surg 2023; 13: 5456-5462.","journal-title":"Quant Imaging Med Surg"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/978-1-0716-2505-7_16","article-title":"Radioactive Iodine for papillary thyroid carcinoma","volume":"2534","author":"Chan","year":"2022","unstructured":"Chan WWL and Kwong DLW. Radioactive Iodine for papillary thyroid carcinoma. Methods Mol Biol 2022; 2534: 225-241.","journal-title":"Methods Mol Biol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"3709","DOI":"10.12998\/wjcc.v10.i12.3709","article-title":"Relationship between subgroups of central and lateral lymph node metastasis in clinically node-negative papillary thyroid carcinoma","volume":"10","author":"Zhou","year":"2022","unstructured":"Zhou J, Li DX, Gao H and Su XL. Relationship between subgroups of central and lateral lymph node metastasis in clinically node-negative papillary thyroid carcinoma. World J Clin Cases 2022; 10: 3709-3719.","journal-title":"World J Clin Cases"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1001954","DOI":"10.3389\/fcell.2022.1001954","article-title":"Potential diagnostic of lymph node metastasis and prognostic values of TM4SFs in papillary thyroid carcinoma patients","volume":"10","author":"Wang","year":"2022","unstructured":"Wang K, Li H, Zhao J, Yao J, Lu Y, Dong J, Bai J and Liao L. Potential diagnostic of lymph node metastasis and prognostic values of TM4SFs in papillary thyroid carcinoma patients. Front Cell Dev Biol 2022; 10: 1001954.","journal-title":"Front Cell Dev Biol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3803\/EnM.2023.1667","article-title":"Lower thyroid cancer mortality in patients detected by screening: a meta-analysis","volume":"38","author":"Moon","year":"2023","unstructured":"Moon S, Song YS, Jung KY, Lee EK and Park YJ. Lower thyroid cancer mortality in patients detected by screening: a meta-analysis. Endocrinol Metab (Seoul) 2023; 38: 93-103.","journal-title":"Endocrinol Metab (Seoul)"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"130850","DOI":"10.1016\/j.bbagen.2025.130850","article-title":"Inhibition of phosphodiesterase 4 and 7 regulates breast cancer cell proliferation","volume":"1869","author":"Justel C","year":"2025","unstructured":"Mayora Justel C, Valladares T, Gargiulo L, González-Pardo V, De Sousa M, Esandi MDC, Davio C, Lüthy I and Bruzzone A. Inhibition of phosphodiesterase 4 and 7 regulates breast cancer cell proliferation. Biochim Biophys Acta Gen Subj 2025; 1869: 130850.","journal-title":"Biochim Biophys Acta Gen Subj"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"106453","DOI":"10.1016\/j.biocel.2023.106453","article-title":"Cancer: phosphodiesterase type 4C (PDE4C), the forgotten subfamily as a therapeutic target","volume":"162","author":"Wright","year":"2023","unstructured":"Wright TA, Gemmell AO, Tejeda GS, Blair CM and Baillie GS. Cancer: phosphodiesterase type 4C (PDE4C), the forgotten subfamily as a therapeutic target. Int J Biochem Cell Biol 2023; 162: 106453.","journal-title":"Int J Biochem Cell Biol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"630","DOI":"10.3390\/biom15050630","article-title":"HNF4α-mediated LINC02560 promotes papillary thyroid carcinoma progression by targeting the miR-505-5p\/PDE4C axis","volume":"15","author":"Su","year":"2025","unstructured":"Su Y, Xu B, Gao C, Pei W, Ma M, Zhang W, Hu T, Zhang F and Zhang S. HNF4α-mediated LINC02560 promotes papillary thyroid carcinoma progression by targeting the miR-505-5p\/PDE4C axis. Biomolecules 2025; 15: 630.","journal-title":"Biomolecules"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"Pan F, Pan R, Hu R, Zhang H, Lei S, Zhang L, Zhou C, Zeng Z, Tian X and Xie Q. Analysis of the effects of M2 macrophage-derived PDE4C on the prognosis, metastasis and immunotherapy benefit of osteosarcoma. J Cell Mol Med 2024; 28: e18395.","DOI":"10.1111\/jcmm.18395"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s13008-023-00101-x","article-title":"Preeclampsia-associated lncRNA FEZF1-AS1 regulates cell proliferation and apoptosis in placental trophoblast cells through the ELAVL1\/NOC2L axis","volume":"18","author":"Zhao","year":"2023","unstructured":"Zhao X, Su F, Guo Q, Tao X, Wang H, Wang H, Li Q and Zhang W. Preeclampsia-associated lncRNA FEZF1-AS1 regulates cell proliferation and apoptosis in placental trophoblast cells through the ELAVL1\/NOC2L axis. Cell Div 2023; 18: 17.","journal-title":"Cell Div"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"114491","DOI":"10.1016\/j.yexcr.2025.114491","article-title":"ELAVL1 facilitates gastric cancer progression and metastasis through TL1A mRNA stabilization","volume":"446","author":"Jiang","year":"2025","unstructured":"Jiang T, Bo S, You Y, Wang Y, Hou L, Tian S, Bai B, Cheng Y and Gao Y. ELAVL1 facilitates gastric cancer progression and metastasis through TL1A mRNA stabilization. Exp Cell Res 2025; 446: 114491.","journal-title":"Exp Cell Res"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"939784","DOI":"10.3389\/fonc.2022.939784","article-title":"ELAVL1 promotes prostate cancer progression by interacting with other m6A regulators","volume":"12","author":"Cai","year":"2022","unstructured":"Cai Z, Xu H, Bai G, Hu H, Wang D, Li H and Wang Z. ELAVL1 promotes prostate cancer progression by interacting with other m6A regulators. Front Oncol 2022; 12: 939784.","journal-title":"Front Oncol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"111112","DOI":"10.1016\/j.cellsig.2024.111112","article-title":"LncRNA HOST2 promotes NSUN2-mediated breast cancer progression via interaction with ELAVL1","volume":"117","author":"Wang","year":"2024","unstructured":"Wang X, Liu D, Hua K and Fang L. LncRNA HOST2 promotes NSUN2-mediated breast cancer progression via interaction with ELAVL1. Cell Signal 2024; 117: 111112.","journal-title":"Cell Signal"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"Liu Y, Xin Y, Shang X, Tian Z and Xue G. CircSEMA6A upregulates PRRG4 by targeting MiR-520h and recruiting ELAVL1 to affect cell invasion and migration in papillary thyroid carcinoma. Arch Endocrinol Metab 2024; 68: e210541.","DOI":"10.20945\/2359-4292-2021-0541"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"Yan K, Liu QZ, Huang RR, Jiang YH, Bian ZH, Li SJ, Li L, Shen F, Tsuneyama K, Zhang QL, Lian ZX, Guan H and Xu B. Spatial transcriptomics reveals prognosis-associated cellular heterogeneity in the papillary thyroid carcinoma microenvironment. Clin Transl Med 2024; 14: e1594.","DOI":"10.1002\/ctm2.1594"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"4062","DOI":"10.1097\/JS9.0000000000002400","article-title":"Clinical performance of a machine learning-based model for detecting lymph node metastasis in papillary thyroid carcinoma: a multicenter study","volume":"111","author":"Liu","year":"2025","unstructured":"Liu W, Zheng J, Han L, Qu W, Wu Q, Yuan Z, Jia G, Wang X, Ye L, Zhang J, Zhang S, Cao X, Liu Y and Ai Z. Clinical performance of a machine learning-based model for detecting lymph node metastasis in papillary thyroid carcinoma: a multicenter study. Int J Surg 2025; 111: 4062-4067.","journal-title":"Int J Surg"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/s41569-022-00756-z","article-title":"Cyclic nucleotide phosphodiesterases as therapeutic targets in cardiac hypertrophy and heart failure","volume":"20","author":"Kamel","year":"2023","unstructured":"Kamel R, Leroy J, Vandecasteele G and Fischmeister R. Cyclic nucleotide phosphodiesterases as therapeutic targets in cardiac hypertrophy and heart failure. Nat Rev Cardiol 2023; 20: 90-108.","journal-title":"Nat Rev Cardiol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1080\/15384101.2021.1944512","article-title":"LncRNA HCP5 promotes malignant cell behaviors in esophageal squamous cell carcinoma via the PI3K\/AKT\/mTOR signaling","volume":"20","author":"Xu","year":"2021","unstructured":"Xu J, Ma J, Guan B, Li J, Wang Y and Hu S. LncRNA HCP5 promotes malignant cell behaviors in esophageal squamous cell carcinoma via the PI3K\/AKT\/mTOR signaling. Cell Cycle 2021; 20: 1374-1388.","journal-title":"Cell Cycle"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"783050","DOI":"10.3389\/fcell.2021.783050","article-title":"PDE4B induces epithelial-to-mesenchymal transition in bladder cancer cells and is transcriptionally suppressed by CBX7","volume":"9","author":"Huang","year":"2021","unstructured":"Huang Z, Liu J, Yang J, Yan Y, Yang C, He X, Huang R, Tan M, Wu D, Yan J and Shen B. PDE4B induces epithelial-to-mesenchymal transition in bladder cancer cells and is transcriptionally suppressed by CBX7. Front Cell Dev Biol 2021; 9: 783050.","journal-title":"Front Cell Dev Biol"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"Jeong MH, Urquhart G, Lewis C, Chi Z and Jewell JL. Inhibition of phosphodiesterase 4D suppresses mTORC1 signaling and pancreatic cancer growth. JCI Insight 2023; 8: e158098.","DOI":"10.1172\/jci.insight.158098"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"6813","DOI":"10.1038\/s41598-024-57533-w","article-title":"Elevated PDE4C level serves as a candidate diagnostic biomarker and correlates with poor survival in thyroid carcinoma","volume":"14","author":"Wang","year":"2024","unstructured":"Wang Y, Zhang Y, Li Y and Huang J. Elevated PDE4C level serves as a candidate diagnostic biomarker and correlates with poor survival in thyroid carcinoma. Sci Rep 2024; 14: 6813.","journal-title":"Sci Rep"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"61247","DOI":"10.1021\/acsomega.5c04518","article-title":"Pan-cancer analysis of cyclic nucleotide phosphodiesterases (PDEs) expression, variation, and prognostic significance","volume":"10","author":"Wu","year":"2025","unstructured":"Wu Z, Ren H and Guo F. Pan-cancer analysis of cyclic nucleotide phosphodiesterases (PDEs) expression, variation, and prognostic significance. ACS Omega 2025; 10: 61247-61255.","journal-title":"ACS Omega"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"3791","DOI":"10.1038\/s41388-020-1258-8","article-title":"PDE4 subtypes in cancer","volume":"39","author":"Hsien Lai","year":"2020","unstructured":"Hsien Lai S, Zervoudakis G, Chou J, Gurney ME and Quesnelle KM. PDE4 subtypes in cancer. Oncogene 2020; 39: 3791-3802.","journal-title":"Oncogene"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.7150\/ijbs.102566","article-title":"BAP31-ELAVL1-SPINK6 axis induces loss of cell polarity and promotes metastasis in hepatocellular carcinoma","volume":"21","author":"Zhang","year":"2025","unstructured":"Zhang X, Wang J, Liang X, Jiang D, Sun Y, Hu C, Hu F, He Y, Sun Y, Zhang J, Ding J, Cai S, Wang Y, Yang S and Yang K. BAP31-ELAVL1-SPINK6 axis induces loss of cell polarity and promotes metastasis in hepatocellular carcinoma. Int J Biol Sci 2025; 21: 1632-1648.","journal-title":"Int J Biol Sci"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"189","DOI":"10.5152\/AnatolJCardiol.2021.40067","article-title":"Circular RNA hsa_circ_0000848 regulates cardiomyocyte proliferation and apoptosis under hypoxia via recruiting ELAVL1 and stabilizing SMAD7 mRNA","volume":"26","author":"Cao","year":"2022","unstructured":"Cao S, Li C, Li L, Zhou G, Jiang Y and Feng J. Circular RNA hsa_circ_0000848 regulates cardiomyocyte proliferation and apoptosis under hypoxia via recruiting ELAVL1 and stabilizing SMAD7 mRNA. Anatol J Cardiol 2022; 26: 189-197.","journal-title":"Anatol J Cardiol"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"Ye W, Liu Z, Liu Y, Xiao H, Tan Q, Yan A and Zhu G. ELAVL1 promotes ferroptosis via the TRIM21\/HOXD8 axis to inhibit osteogenic differentiation in congenital pseudoarticular tibia-derived mesenchymal stem cells. J Cell Commun Signal 2025; 19: e70016.","DOI":"10.1002\/ccs3.70016"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.7754\/Clin.Lab.2015.150404","article-title":"miR-31 reduces cell growth of papillary thyroid carcinoma by RNA-binding protein HuR","volume":"61","author":"Wu","year":"2015","unstructured":"Wu D, Wang B, Shang J, Song J and Zhang H. miR-31 reduces cell growth of papillary thyroid carcinoma by RNA-binding protein HuR. Clin Lab 2015; 61: 1625-1634.","journal-title":"Clin Lab"}],"container-title":["American Journal of Cancer Research"],"original-title":[],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T08:17:30Z","timestamp":1792743450000},"score":1,"resource":{"primary":{"URL":"https:\/\/e-century.us\/files\/ajcr\/16\/2\/ajcr0169719.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":29,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.62347\/vzmv3943","relation":{},"ISSN":["2156-6976"],"issn-type":[{"value":"2156-6976","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]}}}